Scientific Opinion on the substantiation of health claims related to <em>Lactobacillus rhamnosus</em> GR-1 (ATCC 55826) in combination with <em>Lactobacillus reuteri</em> RC-14 (ATCC 55845) and defence against vaginal pathogens by increasing the proportion of lactobacilli and/or decreasing the proportion of potentially pathogenic bacteria and/or yeasts (ID 945) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

Lactobacillus rhamnosus GR-1 (ATCC 55826), Lactobacillus reuteri RC-14 (ATCC 55845), lactobacilli, bacterial vaginosis, yeasts, Nugent score, health claims
First published in the EFSA Journal
30 June 2011
8 April 2011
Scientific Opinion

No abstract available

Panel members at the time of adoption
Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen
Panel on Dietetic Products, Nutrition and Allergies
nda [at]
EFSA Journal 2011;9(6):2232 [15 pp.].
Question Number
On request from
European Commission